The initial characterization of two monoclonal antibodies directed at antigens selectively expressed on large granular lymphocytes (LGL) is reported in the present paper. These two reagents, anti-natural killer (NK) H1A and anti-NKH2, were obtained following immunization of mouse spleen cells with a cloned human NK cell line termed JT3. In fresh human peripheral blood, both anti-NKH1A and anti-NKH2 selectively reacted with cells that appeared morphologically as large granular lymphocytes. However, complement lysis studies and two color fluorescence analysis demonstrated that some LGL express both antigens and other cells express only NKH1A or NKH2. Functional analysis of these subsets indicated that the population of NKH1A+ cells contains the entire pool of NK active lymphocytes, whereas expression of NKH2 antigen appeared to delineate a unique subpopulation of LGL which, in a resting state, display a low degree of spontaneous cytotoxicity. Expression of NKH1A and NKH2 was also investigated using a series of nine well characterized human NK clones. All NK clones were found to be NKH1A+ and four out of nine also expressed NKH2. These results strongly supported the view that NKH1A is a "pan-NK" associated antigen, and indicated that at least a fraction of cloned NKH2 + LGL are strongly cytotoxic. Anti-NKH1A was shown to have the same specificity as the previously described N901 antibody and was found here to precipitate […] 
Introduction
The initial characterization of two monoclonal antibodies directed at antigens selectively expressed on large granular lymphocytes (LGL) is reported in the present paper. These two reagents, anti-natural killer (NK) HiA and anti-NKH2, were obtained following immunization of mouse spleen cells with a cloned human NK cell line termed JT3. In fresh human peripheral blood, both anti-NKHlA and anti-NKH2 selectively reacted with cells that appeared morphologically as large granular lymphocytes. However, complement lysis studies and two color fluorescence analysis demonstrated that some LGL express both antigens and other cells express only NKH1A or NKH2. Functional analysis of these subsets indicated that the population of NKH1A+ cells contains the entire pool of NK active lymphocytes, whereas expression of NKH2 antigen appeared to delineate a unique subpopulation of LGL which, in a resting state, display a low degree of spontaneous cytotoxicity. Expression of NKH1 and NKH2 was also investigated using a series of nine well characterized human NK clones. All NK clones were found to be NKH1A+ and four out of nine also expressed NKH2. These results strongly supported the view that NKH1A is a "pan-NK" associated antigen, and indicated that at least a fraction of cloned NKH2+ LGL are strongly cytotoxic. Anti-NKHlA was shown to have the same specificity as the previously described N901 antibody and was found here to precipitate a 200,000-220,000-mol wt molecule in SDSpolyacrylamide gel electrophoresis (PAGE) analysis. Anti-NKH2 was specific for a structure that migrates at 60,000 mol wt in SDS-PAGE analysis under reducing conditions. Two color immunofluorescence analysis of NKH1A, NKH2, and other NK-associated antigens (Leu7 and B73.1) demonstrated variable degrees of coexpression of these antigens, which confirmed that NKHlA and NKH2 define distinct cell surface structures. Anti-NKHlA and anti-NKH2 appear to be useful reagents for characterizing LGL present in human peripheral blood and for identifying functionally relevant subsets within this heterogeneous population of cytotoxic lymphocytes.
Dr. Hercend is a fellow of the Leukemia Society of America. Dr (1) (2) (3) . In order to dissect this heterogeneity and study individual NK cells, we have recently developed techniques for generating cloned NK cell lines using lymphocyte-conditioned medium containing interleukin 2 (IL-2). This has led to the development of a series of human NK clones that maintained consistent cytotoxic activity and appeared to reflect the diversity of uncultured peripheral blood NK cells (4, 5) . These NK clones could be classified into three groups by analysis of cell surface markers. One group was shown to be phenotypically similar to mature T lymphocytes and major histocompatibility complex (MHC) restricted cytotoxic T cell clones. Cells in this group express T3 antigen in addition to T8 and TlI antigens and thus appear to have a complete mature T cell phenotype. Moreover, clones in this group have also been shown to express clonotypic receptor like structures, linked to T3 antigen in an analogous fashion to antigen-specific T cells (6) . The second group of NK clones express different combinations of T lymphocyte-associated surface antigens including T1, T8, Tl 1, and/or T12, but lack the mature T cell differentiation antigen, T3. Cells in the third group of NK clones do not express any T cell-associated markers or any other lineage related differentiation antigens. In addition to providing a means for demonstrating the phenotypic heterogeneity of NK cells, characterization of NK clones has also suggested that individual NK cells have different restricted target cell specificities (5) .
Although analysis of cloned NK cell lines has provided useful information about NK active lymphocytes at the single cell level, it is also evident that the generation of clones is dependent upon the capacity of individual cells to proliferate in conditioned medium containing IL-2. It is not known at the present time whether all the different types of cells capable of mediating NK activity can respond to IL-2 under these experimental conditions and it is therefore possible that some subsets of NK cells cannot be characterized using this approach.
In order to define directly in fresh human peripheral blood both the entire pool of NK active lymphocytes and functional subsets within this fraction, we have also used NK clones for the generation of monoclonal antibodies that would selectively react with these small populations of cells. In the present studies, a previously described human NK clone termed JT3 (5) , which has a very common NK phenotype (T3-T4-T8-T 1 +N901 +), was used as immunogen for production of murine hybridomas. After Isolation of subpopulations of peripheral blood cells. Human peripheral blood mononuclear cells (PBMC) were isolated from healthy volunteer donors by Ficoll-Hypaque (F/H) density gradient centrifugation. Monocyte enriched adherent cells were obtained from PBMC by two step adherence on plastic culture dishes. Granulocytes were isolated from F/H gradient pellets using high molecular weight dextran (8) . Activated T cells were generated by stimulating E+ cells with phytohemagglutinin (PHA) (2 ,ug/ml) and tested on day 7 after stimulation.
Previously characterized monoclonal antibodies. Several monoclonal antibodies utilized in these studies have been previously described in detail. Anti-T3 defines all mature T lymphocytes in human peripheral blood (9) . T8 antigen is expressed on a subset of peripheral T cells having primarily cytotoxic/suppressor function (10) . T4 is expressed on a subset of peripheral T cells having primarily inducer/helper function (11) . Anti-Tll defines an antigen associated with the sheep erythrocyte receptor ( 12) . In peripheral blood, N901 antigen is expressed on -7% of cells which morphologically appear to be a homogeneous population of LGL. Greater than 95% of NK activity in peripheral blood is found within the purified 901+ fraction. Anti-901 antibody does not react with monocytes, granulocytes, B cells, erythrocytes, or platelets (8) . The specificity of anti-I2 (anti-Ia) has been previously described in detail (13) . Anti-Mo2 defines a 55,000-mol wt molecule selectively expressed on human monocytes (14) . Other NK-associated antibodies used in these studies were HNK-1 (15) and B73.1 (16).
B73. 1 defines an antigen associated with IgG Fc receptor expressed on some LGL and on granulocytes (17) .
Phenotypic analysis of cell surface antigens. Phenotypic analysis was performed by indirect immunofluorescence with fluorescein-conjugated goat anti-mouse Fab IgG (GM-FITC) as described previously (4 Electronic compensation for the small overlaps of fluorescein fluorescence on the PE detector and PE fluorescence on the fluorescein detector yielded signals essentially identical to those with either reagent used alone. 10,000 cells were analyzed in each sample and results displayed as an orthographic projection looking down on an x, y axis plotting log green fluorescence (FITC) versus log red fluorescence (PE).
Complement lysis experiments. Cells were incubated with either anti-NKHIA or anti-NKH2 antibodies at a concentration of 25 X 106 cells/ml in RPMI 1640 containing 2.5% pooled human AB serum for 30 min at room temperature. Cells were then washed in serum-free medium and rabbit complement was added at 1:10 final dilution in serum-free medium for 45 min at 37°C. In all experiments presented here, the entire procedure was repeated two times.
Purification of NKH2+ cells. For enrichment of NKH2+ cells by immune rosetting technique, PBMC were incubated at a concentration of 25 X 106 cells/ml for 30 min at 40C with saturating amounts of anti-Ia, anti-Mo2, and anti-T4. Unbound antibody was removed by two wash steps. To form immunorosettes, monoclonal antibodytreated cells were mixed with a 10% anti-Ig coated erythrocyte suspension at a ratio of 0.75 ml for 108 peripheral blood lymphocytes (PBL). The mixture was pelleted (300 g, 10 min) and incubated for 20 min at 4°C. Ig-coated erythrocytes were prepared as previously described ( 18 5,000 rad irradiated Laz 388 (0.5 X 106/ml). The cells were then washed four times to remove the mitogens and resuspended in RPMI 1640 supplemented with 2.5% human AB serum. After 40 h of incubation at 370C, the supernatants were harvested, passed through 0.45-,um filters, and stored at -70'C.
Cytotoxicity assays. Cytotoxicity assays were performed according to a standard chromium release method previously described (4) . All experiments were done in triplicate using V bottom microtiter plates. Medium was RPMI 1640 plus 5% pooled human AB serum and 1% penicillin streptomycin. Assays were performed at various effector/ target ratios using 5,000 target cells/well. JM and Molt-4 are T cell leukemia cell lines whereas K562 was established from a patient with chronic myelogenous leukemia.
"2SI surface labeling and immunoprecipitation ofantigens from JT3 cloned cells. Cells were surface labeled with 125I (New England Nuclear, Boston, MA) using a standard lactoperoxidase method previously described (5). 2 X 107 viable, proliferating JT3 cells were washed with RPMI 1640 and resuspended in PBS and labeled with I MCi 1251 for 15 min at room temperature followed by addition of 100 Ml Nal (I mol/liter). Labeled cells were then harvested and washed three times in cold RPMI 1640. Cell lysate was prepared by resuspending the cell pellet in 300 Ml RIPA buffer, pH 7.5, containing 1% Triton X-100, 0.15 M NaCl, 0.01 M NaH2PO4, I mM EDTA, 1 mM EGTA, 1 mM NaF, I mM phenylmethylsulfonyl fluoride, and Trypsin inhibitor and agitated for 40 min at 4°C. Cell lysates were stored at -70°C before use.
Immune precipitation of N901 and NKH1A antigens were carried out using preformed complexes of rabbit anti-mouse Ig and specific monoclonal antibody as previously described (19). Precipitation of NKH2 antigen was performed using anti-NKH2 antibody bound to CnBr-activated Sepharose 4B. Before being bound to CnBr-activated Sepharose 4B, anti-NKH2 was purified using a standard ammonium sulfate precipitation procedure. In both cases, macromolecular aggregates were removed from cell lysate by ultracentrifugation for 30 min at 100,000 g. Cell lysates were then precleared three times by incubation at 4°C for 1 h with either formalin fixed Staph A bacteria and/or preformed complexes of rabbit anti-mouse Ig and nonspecific monoclonal antibody. Aliquots of precleared lysate were then incubated with specific preformed complexes or with antibody-coated Sepharose beads for 2 h at 4°C. Immune precipitates were then washed four times with radioimmune precipitation assay buffer as above and dissolved in SDSpolyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and loaded onto separate slots on a 10% polyacrylamide slab gel. Identical aliquots of immune precipitation were run in nonreduced and reduced conditions after addition of 2-mercaptoethanol to SDS-PAGE sample buffer. Gels were dried and radiolabeled precipitates were visualized using standard methods (20) .
Results
Generation and cellular reactivity of anti-NKHIA and anti-NKH2 monoclonal antibodies. Anti-NKHlA and anti-NKH2 hybridoma antibodies were obtained in a series of fusion experiments with mouse spleen cells immunized against cloned JT3 cells. JT3 is a human cloned NK cell line that has been previously described in detail (5 some LGL could exclusively express one or the other antigen. To address this question, LGL-enriched fractions were obtained using an immunorosette depletion technique described in Methods. Using this method, PBMC were separated in two fractions (T4, Mo2, Ia)+ (LGL depleted) and (T4, Mo2, Ia)-(LGL enriched). Anti-T4, anti-Ia and anti-Mo2 antibodies were utilized in these experiments because it had been previously been shown that T4, Ia, and Mo2 antigens were not expressed on LGL to any significant degree (8, 14, 22) . This procedure resulted in the specific depletion of the majority of T lymphocytes (T4+), B lymphocytes (Ia+), and monocytes (Ia+, Mo2+) from circulating PBMC. Over To investigate the possible presence of both NKHlA+ NKH2-and NKHlA-NKH2+ LGL subsets in peripheral blood, LGL-enriched fractions obtained by immunorosette depletion were treated with either anti-NKH1A or anti-NKH2 plus complement. After lysis, remaining viable cells were tested using indirect immunofluorescence assays and cell sorter analysis for expression of NKH 1A and NKH2. In these experiments, it was found that treatment with one or the other antibody did not totally eliminate cells expressing the reciprocal antigen. A representative experiment illustrating these results is presented in Fig. 3 . Unseparated PBMC from this donor-contained 14% NKHIA+ cells and 9% NKH2+ cells (Fig. 3 A) . After immunorosette depletion, 69% NKHlA+ cells and 30% NKH2+ cells were present in the LGL enriched (T4, Mo2, Ia)-fraction (Fig. 3 B) . When cells from this latter fraction were reanalyzed following treatment with anti-NKH2 plus complement, the reactivity of anti-NKH2 was reduced to 3%, whereas the reactivity of anti-NKHlA was 68% (Fig. 3 C) . Reciprocally, following lysis with anti-NKHIA, the percent cells reactive with NKHlA was reduced to 15%, but 35% of NKH2+ cells were still present (Fig. 3 D) . As shown in Fig. 3 , complement lysis with anti-NKH2 was generally more efficient than with anti-NKH IA . Using the latter antibody, it was very difficult to eliminate cells displaying very low antigen density. This series of experiments strongly suggested that even though both antigens were exclusively expressed on LGL populations, both NKH1A+ NKH2-LGL and NKHIA-NKH2+ LGL subsets were also present in peripheral blood. Two color immunofluorescence analysis of nonadherent PBMC. Both anti-NKHlA and anti-NKH2 were obtained after immunization of mice with a single population of cloned cells, and both antibodies reacted specifically with LGL, which represent only a minor fraction of circulating lymphocytes. It was therefore likely that in addition to LGL expressing either NKHlA or NKH2, a third population of cells could coexpress both antigens. To demonstrate this point, PBMC were analyzed using two color immunofluorescence with both anti-NKH1A-FITC and anti-NKH2-biotin/AV-PE. In a similar fashion, NKHlA-positive cells and NKH2-positive cells were also tested for coexpression of T3, T 1 1, and Ia antigens. Before dual color analysis, freshly isolated mononuclear cells were depleted of monocytes by a 1-h adherence in large plastic dishes at 37°C, but no other enrichment procedures were used in order to avoid potential artifacts that could result from further immunologic manipulation. As shown in Fig. 4 , a distinct subset of NKH1A positive cells coexpresses NKH2 antigen. In addition, the large majority of both NKH1A or NKH2-positive cells coexpressed T 11 antigen, a smaller subset coexpressed T3 antigen, but very few cells also coexpressed Ia antigens. Specifically, of the NKH1A positive cells in this individual, 29% were NKH2+, 39% were T3+, 83% were Tl 1 + and 1% were Ia+. Within the NKH2-positive population, similar percentages of cells coexpressed these same antigens: 38% were T3+, 79% were Tll+, and 3% were Ia+.
Expression of NKHIA and NKH2 antigens on human cloned NK cell lines. In addition to studying unstimulated peripheral blood cells, a large panel of cloned NK cell lines was also used in order to evaluate the expression of NKH1A and NKH2 at the single cell level. As with the two color immunofluorescence studies, characterization of these NK clones also allowed an analysis of the coexpression of NKH 1A and NKH2 with additional antigens such as T3, T 11, and N901. The reactivity of anti-NKHlA and anti-NKH2 was tested using a series of nine cloned NK cell lines (Table II) . JT1, JT3, JT9, and JT10 have been previously described in detail (5, 6) . JTlI was a clone derived from the same donor. It was found to express the NKTa clonotypic determinant as well as JT9 and JT10 (6) . The lytic specificity of JT As shown in Table II , NKH1A was present on all clones that had been selected on the basis of one unique criteria, e.g., the capacity of killing K562 cells without apparent preimmunization. In addition, it was found that the reactivity of anti-NKH1A on these cloned NK cell lines was virtually superimposable to that of the previously described anti-N90 1 antibody.
The expression of NKH2 was distinct from that of NKH1A since only four of the nine NK clones were NKH2+. NKH1A and NKH2 were coexpressed on JTl, JT3, and JT16 and JTA17 cells. JTl has a very unique phenotype, since it does not express any T cell associated antigens. JT3 and JT16 are phenotypically identical when tested with the presently available antibodies. Both clones are T3-,T4-,T8-,T 11 +,N90 1+, and this appears to represent one very common phenotype of fresh peripheral blood NK cells (8) . NKH2 was not present on JT9, JT10, and JT11, which all express the NKTa clonotypic determinant, and was also not found on JT15, which is an additional clone with mature T cell (T3+) phenotype. Nevertheless, JTA17 cells, which also express T3 antigen, were very strongly NKH2+, which indicated that at least some NK cells with mature T cell phenotype can express this antigen as well as other NK active cells. Interestingly, JTB18, previously considered to share identical surface markers with JT3 and JT16, was found to be NKH2-. It was also noted that for each clone the reactivity of anti-NKH2 was either <1% of the cells or >95%. In addition, each NKH2+ clone was found to express relatively large amounts of antigen, and the reactivity with anti-NKH2 antibody was stable from one determination to another. The expression of NKH2 was also tested using nine additional, well characterized MHC restricted human T cell clones without NK activity (kindly provided by Dr. Stefan Meuer, Johannes-Gutenberg-Universitiit, Mainz, Federal Republic of Germany), and all were found to be negative (data not shown). Two representative experiments are shown in Fig. 6 . As expected, most, if not all, spontaneous cytotoxicity present in human peripheral blood was found in the (T4, Mo2, Ia)-fraction, whereas little if any NK activity was displayed by cells of the reciprocal (T4, Mo2, Ia)+ subset. More importantly, in five of six experiments, it was found that NKH2+ LGL had low NK activity, whereas (T4, Mo2, Ia)-NKH2-cells displayed a level of cytotoxicity that was the same or slightly higher than that of the unsorted (T4, Mo2, Ia)-lymphocytes. Only in one of six experiments was the NK activity displayed by NKH2+ cells almost as strong as that present in the (T4, Mo2, Ia)-fraction. To ensure that the low NK activity displayed by NKH2+ sorted cells was not due to a blocking effect of anti-NKH2 antibody, we again took advantage of the Characterization of NKHIA, N901, and NKH2 antigens. Immunoprecipitation experiments were conducted to identify the molecular weight of the antigens defined by anti-NKHIA and anti-NKH2. An additional antibody, anti-N901, which has been previously shown to react with NK cells, was studied in parallel because the present results suggested that NKH1A and N901 may represent the same antigens. In addition, the molecular weight of N901 had not been previously described (8) .
Immunoprecipitations of the NKH2 antigen from 125i-labeled JT3 cells were performed using purified anti-NKH2 antibody bound to CnBr activated Sepharose 4B as described in Methods. Under reducing conditions, anti-NKH2 precipitated a single band of 60,000 mol wt in SDS-PAGE. Under nonreducing conditions, two bands, one at -120,000 and one at 60,000 mol wt, were seen in three out of four experiments. In one of four experiments, only a single band at 60,000 mol wt was obtained in both reducing and nonreducing conditions. It is therefore possible that the 120,000-mol wt band corresponded to aggregates of the monomeric 60,000-mol wt structure (Fig. 7) .
To characterize NKHlA and N901 antigens, immunoprecipitations were done using preformed complexes of rabbit anti-mouse Ig with either anti-N901 or anti-NKHlA antibodies. These preformed complexes were reacted with 1251 surface labeled JT3 cell lysates as described in Methods. As shown in Fig. 8 , both anti-N901 and anti-NKHlA precipitated a broad band at -200,000-220,000 mol wt. Additional experiments were performed in which the precipitates were analyzed using 5-15% polyacrylamide gradient, and no additional specific bands were identified (data not shown). However, when gradient gels were used, the specific band was seen at a slightly lower molecular weight (180,000-200,000 mol wt) as compared with the 10% polyacrylamide gels.
To confirm that anti-NKH1A and anti-N901 were directed at the same molecule, a series of competitive binding experi- resolved by SDS-PAGE using 10% polyacrylamide gels as described in Methods. Controls were overexposed to identify nonspecific bands. Radiolabeled standards were run in parallel with immunoprecipitates. A, negative control beads (MY4), nonreduced; B. anti-NKH2 coated beads, nonreduced; C, negative control beads, reduced; D, anti-NKH2 coated beads, reduced. of isotype between the two antibodies (anti-NKHlA being an IgM and anti-N901 being an IgGl). Using isotype specific FITC in indirect immunofluorescence assays, it was found that anti-N901 effectively blocked binding of anti-NKHIA, whereas anti-NKHIA did not significantly affect binding of anti-N901 (data not shown). These results confirmed that both antibodies were specific for the same cell surface antigen and also suggested that the IgG I antibody (anti-N901) had a higher affinity than the IgM (anti-NKHlA).
Coexpression of NKHJA and NKH2 with other NK-associated antigens. In order to determine whether the LGL subsets identified by anti-NKHIA and anti-NKH2 corresponded to those previously identified by other NK-associated antigens, simultaneous two color immunofluorescence studies were undertaken as described previously (Fig. 4) with T cell antibodies anti-T3 and anti-Tl 1, and with Ia antigen. The other antibodies used in these experiments were HNK-1 (Leu7) and B73.1 (Leul lc). Leu7 is reported to be reactive with the majority of NK active cells in peripheral blood and is also reactive with some T cells that do not have NK activity (15, 23) . B73.1 is specific for the IgG Fc receptor that is expressed on cells mediating NK and antibody-dependent cellular cytotoxicity (ADCC) as well as mature granulocytes (16, 17) . The reactivity of B73.1 is similar to that described for NKP-15 (24, 25) and VEP 13 (26) .
In the two color immunofluorescence analysis shown in Fig. 9 (unpublished data) , are NKH2-. Nevertheless, the similarity of molecular weight between B73. 1 and NKH2 might still suggest that these two NK-associated antigens belong to the same family of molecules.
In summary, the present studies suggest that anti-NKHIA and anti-NKH2 are capable of dissecting populations of LGL into distinct functional subsets with varying levels of NK activity. Using these two antibodies, LGL can be divided into three populations: NKHlA+,NKH2+; NKHIA+,NKH2+; and NKH 1 A+,NKH2-. Since NKH2+ cells were found to display low NK activity in the resting state, the latter subset appears to contain the most strongly cytotoxic cells in peripheral blood of most normal individuals.
LGL in the first subset that express both NKH1A and NKH2 antigens can display strong cytotoxicity when activated, such as in cultured NK clones, but the functional activity of these cells in unstimulated peripheral blood has not yet been determined. Finally, the function of LGL that express NKH2 antigen only has not been evaluated in this study, but no NK clones representing this phenotype have yet been found, and there is no evidence to indicate that these cells have significant NK activity in peripheral blood. Further studies utilizing dual immunofluorescence markers will be able to purify these different fractions and characterize their respective function in a resting state as well as following activation. Hopefully, the identification of this series of NKassociated antigens will lead to a better understanding of the diversity of NK cells, and ultimately help to clarify both their lineage derivation and biological significance.
